Neurovascular stents industry analysis

Technavio’s market research report predicts that the global neurovascular stents market will grow at a CAGR of above 13% during forecast period. High incidence rates of neurovascular disorders are the primary drivers of market growth. Rising disorders like a brain aneurysm, stenosis, ischemic stroke, and other illnesses drive the market’s growth. Moreover, factors like growth in unhealthy diet, less physical activity, excessive alcohol consumption, smoking, stress, blood glucose, and lipids are some of the other major causes for cerebral aneurysms.

Additionally, the occurrence of a cerebral aneurysm is common in women, and high blood pressure is one of the chief factors for a ruptured aneurysm. For example, based on the CDC 2014 statistics, the number of adults with stroke were about six million in the US and the number of deaths due to stroke was close to a million.

Neurovascular stents market share based on geography

In terms of geography, the Americas dominated the global neurovascular stents market during 2016 and is expected to continue the domination over the next four years. The rising occurrences of cerebral disorders like stenosis, malformation, and brain aneurysm drives the growth of the market in the region. Moreover, the acceptance of minimally invasive neurovascular stenting procedures augments the market progress.    

Neurovascular stents market growth: Competitive analysis and key vendors

The global neurovascular stents market consists of a few global players taking up the major share of the total market. The market competition is likely to intensify among the vendors based on technological enhancements and innovative product launches. The manufacturers in the market develop and bring in new products to enhance the patient satisfaction, and the global players are fusing in with improved technologies and concentrating on service support offerings.

Key players in the neurovascular stents market

• Abbott Laboratories
• Medtronic
• Stryker
• Terumo Medical

Neurovascular stents market segmentation by product-type 

• Carotid artery stents
• Intracranial stents

During 2016, the carotid artery stents led the product-type segment of the global neurovascular stents market and are expected to continue the dominion over the next four years. The rising occurrence of a cerebral and brain aneurysm is anticipated to increase the need for carotid artery stents. Moreover, the increasing clinical trials along with the rise of technologically improved products is foreseen to drive the growth of the market.

Neurovascular stents market segmentation by end-user 

• Hospitals
• ASCs

As per the Technavio’s market research report, the hospitals led the global neurovascular stents market during 2016. Factors like the capital investment for surgeries in large hospitals specifically for minimally invasive procedures and the rise in the number of mid-sized hospitals propel the market’s progress in the future.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global neurovascular stents market?
• What are the key market trends impacting the growth of the global neurovascular stents market?
• What are the challenges to market growth?
• Who are the key vendors in the global neurovascular stents market?
• What are the market opportunities and threats faced by the vendors in the global neurovascular stents market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global neurovascular stents market?

Technavio also offers customization on reports based on specific client requirement.